Hudson Bay Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Hudson Bay Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-50,000	Closed	-$3.15M	–	590
2020 Q1	$3.15M	Buy	+50,000	New	+$4.49M	0.08%	208
2019 Q4	–	Sell	-30,000	Closed	-$1.99M	–	530
2019 Q3	$1.99M	Hold	30,000	–	–	0.05%	258
2019 Q2	$2.39M	Buy	+30,000	New	+$2.69M	0.05%	253
2018 Q1	–	Sell	-30,000	Closed	-$1.75M	–	898
2017 Q4	$1.75M	Buy	+30,000	New	+$1.89M	0.04%	344
2014 Q4	–	Sell	-20,000	Closed	-$4.73M	–	234
2014 Q3	$4.73M	Buy	+20,000	New	+$5.1M	0.13%	104

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Hudson Bay Capital Management's ICPT Position: Q2 2020 in Review

Hudson Bay Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 50,000 shares — an estimated $3.15M sold.

Hudson Bay Capital Management first reported a position in ICPT in Q3 2014 and held it in 5 quarters. The position peaked at $4.73M in Q3 2014. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

Hudson Bay Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Hudson Bay Capital Management sold 50,000 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $3.15M.
Hudson Bay Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 5 quarters.
Hudson Bay Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $4.73M in Q3 2014.
192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.